Health Conditions

Zendo Project: Providing Support During Non-Ordinary States of Consciousness

Zendo Project shares insights on supporting individuals in non-ordinary states of consciousness, offering skills and practical tips for helping during psychedelic or emotional crises.

Valerie Beltran, Steve Bagley, Chelsea Rose

PS2023 Cannabis Health Conditions Psychedelic Assisted Therapy PTSD Research and Science Veterans

Phase 2 Multicenter Randomized Placebo-controlled, Double-blind Study to Assess Safety/Efficacy of Inhaled Cannabis in Veterans for PTSD

Study aims to re-examine inhaled cannabis for treating PTSD, with Phase 2 study assessing high THC cannabis versus placebo for managing symptoms and pain in 360 veterans across U.S.

Sue Sisley, Shane Pennington

PS2023 Depression Health Conditions Psilocybin Psychedelic Assisted Therapy Psychotherapy Research and Science

Psilocybin-assisted therapy for frontline clinicians

Study investigates psilocybin's effects on depression and burnout in healthcare clinicians post-COVID frontline work with pre- and post-dose psychotherapy. Trial registration: NCT05163496.

Anthony L Back

PS2023 Depression Health Conditions Ketamine Psychedelic Assisted Therapy Psychedelic Science Research and Science

A trial of ketamine masked by surgical anesthesia in depressed patients

Ketamine and other psychedelics show promise for psychiatric disorders, but their psychoactive effects complicate masking in trials. A triple-masked trial on 40 patients with depression found surprising results.

Boris D. Heifets

PS2023 Depression Health Conditions Psilocybin Psychedelic Assisted Therapy Research and Science

The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder

Psilocybin therapy tested for safety, feasibility, and efficacy in cancer patients with major depressive disorder, using group treatment in a cancer center setting. Clinical trial details: NCT04593563.

Betsy Jenkins

PS2023 Harm Reduction Health Conditions Integration Psilocybin Psychedelic Assisted Therapy Research and Science

Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations

Clinicians and researchers discuss integrating psilocybin-assisted therapy into serious illness care models, presenting preliminary findings from a pilot study in hospice care for patients with terminal illness.

Yvan Beaussant, Roxanne Sholevar, Lisa Summer, Robin McKenna

PS2023 Anxiety Depression Health Conditions Psilocybin Psychedelic Assisted Therapy Research and Science

Psilocybin Therapy in Advanced Cancer

Psilocybin trial for advanced cancer patients will compare effects of 25mg dose to 1mg placebo on anxiety, depression, and existential distress, using psychotherapy to assess efficacy and psychological mechanisms.

PS2023 Health Conditions Psilocybin Psychedelic Assisted Therapy Research and Science Therapy Ethics

Panel discussion on psilocybin therapy for cancer patients and palliative care

Dr. Smith and Dr. Jones explore the latest research on psychedelic therapy and its potential impact on mental health during the PS2023 conference.

Stacy Fischer, Anthony “Tony” Bossis, Charles S Grob, Manish Agrawal, Shoshana Ungerleider

PS2023 Harm Reduction Health Conditions Ketamine Psychedelic Science Research and Science Substance Use Disorder

The Mirror Molecule: How can ketamine and other substances be both addictive and anti-addictive?

Ketamine and psilocybin show promise for health conditions but come with risks, including addiction. This talk challenges the view of drugs as neutral tools and explores their complex nature and

Elias Dakwar

PS2023 Health Conditions Psilocybin Psychedelic Assisted Therapy Research and Science

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study

Study investigates oral psilocybin effects on OCD symptoms and neural mechanisms mediating therapeutic effects. Clinical trial information available at NCT03356483.

Benjamin Kelmendi, Terence Ching